Presentation is loading. Please wait.

Presentation is loading. Please wait.

HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated.

Similar presentations


Presentation on theme: "HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated."— Presentation transcript:

1 HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy, Jin-Seok Ahn, Bohuslav Melichar, Shin-Cheh Chen, Sung-Bae Kim, Mikhail Lichinitser, Elżbieta Starosławska, Georg Kunz, Silvia Falcon, Shou-Tung Chen, Aulde Crepelle-Fléchais, Dominik Heinzmann, Mona Shing, Xavier Pivot European Journal of Cancer Volume 62, Pages 62-75 (July 2016) DOI: 10.1016/j.ejca.2016.03.087 Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

2 Fig. 1 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

3 Fig. 2 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

4 Fig. 3 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

5 Fig. 4 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

6 Fig. 5 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

7 Fig. 6 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions

8 Fig. 6 European Journal of Cancer 2016 62, 62-75DOI: (10.1016/j.ejca.2016.03.087) Copyright © 2016 The Author(s) Terms and Conditions Terms and Conditions


Download ppt "HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated."

Similar presentations


Ads by Google